SSI Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-570
Closed -$200K – 312
2021
Q2
$200K Buy
+570
New +$173K 0.01% 316
2018
Q4
– Sell
-638
Closed -$223K – 260
2018
Q3
$223K Buy
+638
New +$220K 0.02% 280
2018
Q2
– Sell
-752
Closed -$206K – 291
2018
Q1
$206K Sell
752
-13
-2% -$4.04K 0.02% 299
2017
Q4
$245K Hold
765
– – 0.02% 281
2017
Q3
$240K Sell
765
-5
-0.6% -$1.48K 0.02% 288
2017
Q2
$209K Sell
770
-11
-1% -$2.91K 0.02% 299
2017
Q1
$212K Hold
781
– – 0.02% 289
2016
Q4
$223K Sell
781
-1
-0.1% -$296 0.02% 278
2016
Q3
$246K Buy
+782
New +$232K 0.02% 264
2016
Q2
– Sell
-783
Closed -$204K – 280
2016
Q1
$204K Hold
783
– – 0.02% 257
2015
Q4
$238K Hold
783
– – 0.02% 252
2015
Q3
$228K Hold
783
– – 0.02% 252
2015
Q2
$316K Sell
783
-2
-0.3% -$803 0.03% 237
2015
Q1
$331K Sell
785
-838
-52% -$330K 0.03% 240
2014
Q4
$552K Buy
1,623
+567
+54% +$183K 0.06% 210
2014
Q3
$350K Buy
1,056
+240
+29% +$79.1K 0.03% 282
2014
Q2
$257K Sell
816
-8
-1% -$2.41K 0.02% 340
2014
Q1
$252K Sell
824
-692
-46% -$220K 0.03% 348
2013
Q4
$423K Hold
1,516
– – 0.04% 342
2013
Q3
$365K Hold
1,516
– – 0.03% 353
2013
Q2
$326K Buy
+1,516
New +$324K 0.03% 356

Other funds holding BIIB

SSI Investment Management's BIIB Position: Q3 2021 in Review

SSI Investment Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 570 shares — an estimated $200K sold.

SSI Investment Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $552K in Q4 2014. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • SSI Investment Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • SSI Investment Management sold 570 Biogen shares in Q3 2021, an estimated $200K.
  • SSI Investment Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
  • SSI Investment Management's Biogen position peaked at $552K in Q4 2014.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on SSI Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.